Addyi, a new female libido pill, will hit the market this fall, but the prescription drug was twice rejected by the FDA in the past. For a closer look at the uses and risks, Judy Woodruff speaks to Dr. Adriane Fugh-Berman of the Georgetown University Medical Center and Dr. Mary Jane Minkin of Yale Medical Group.
View the full story/transcript:
Why Some Doctors Are Wary Of The New Female Libido Pill For Country: United States. City: Huntsville, Johnson City, Salinas, Toledo, Tucson
